RBI & SEBI

Appellate tribunal rules corporate amalgamations cannot require redundant regulatory no-objection certificates

Originally reported by Taxguru Corporate Law as: Corporate Law | Merger Approval Cannot Be Conditional on Unnecessary RBI and ED Certifications: NCLAT Delhi

21 Nov 2026, 11:09 pm IST · Xecute.finance News Desk

The crisp read

The New Delhi bench of the National Company Law Appellate Tribunal (NCLAT) ruled that tribunals cannot condition corporate amalgamations on unnecessary approvals from the Reserve Bank of India (RBI) and the Enforcement Directorate (ED). The judgment removes bureaucratic delays for restructuring entities unless actual statutory violations exist. Companies undergoing mergers must review compliance strategies accordingly.

Xecute Impact Breakdown

For CAs

  • Corporate legal advisors and chartered accountants managing restructuring schemes must verify whether regulatory objections are substantiated by actual statutory violations before filing responses.
  • Watch for forthcoming tribunal orders citing this precedent to streamline pending amalgamation applications.

For businesses

  • This ruling accelerates corporate restructuring timelines by curbing unwarranted delays from non-jurisdictional regulatory interventions.

Deep dive – the full story

Corporate legal advisors and chartered accountants managing restructuring schemes must verify whether regulatory objections are substantiated by actual statutory violations before filing responses.

Watch for forthcoming tribunal orders citing this precedent to streamline pending amalgamation applications.

Bottom line: this ruling accelerates corporate restructuring timelines by curbing unwarranted delays from non-jurisdictional regulatory interventions.

Source: taxguru.in

This is news/educational content, not investment advice. Xecute.finance is not SEBI-registered. Consult a qualified professional before acting.

More from the Xecute news desk

Reading the static edition.

The live app adds Ask Xecute, deadline trackers, the daily quiz and one-tap deep dives.

Open this story in the Xecute app →